Shyam Dhani Industries

Quick take: Shyam Dhani Industries — a Jaipur-based spices and allied-agro products manufacturer — launched a small SME IPO in late December 2025 with a price band of ₹65–₹70 per share and a lot size of 2,000 shares. Grey Market Premium (GMP) started strong, signalling expectations of meaningful listing gains, but investors should treat GMP as volatile and unofficial. Below is a full breakdown: facts, fundamentals, valuation math and a balanced investor view.

Shyam Dhani Industries IPO (key facts)

Issuer: Shyam Dhani Industries Ltd (SME IPO).
Price band: ₹65 – ₹70 per equity share.
Lot size: 2,000 shares (application amount at upper band ₹70 × 2,000 = ₹140,000 per lot).
IPO open / close: Dec 22, 2025 – Dec 24, 2025 (anchor/other windows reported around Dec 19–22).
Issue size: ~₹36–38 crore (fresh issue / SME issue size reported in filings/news).
Proposed listing: NSE EMERGE (SME platform).

Grey Market Premium (GMP)

Unofficial GMP reports for Shyam Dhani were elevated in the run-up to the offer:

Business Standard reported a GMP ~50% in a headline about the IPO buzz.
Independent IPO trackers reported GMP values in the ₹30–₹31 range — which, relative to the upper band ₹70, implies expected listing gains in the ~44% range.

Important reminder: GMPs are unofficial, short-term indicators derived from the grey market and can change rapidly (sometimes intra-day). They reflect sentiment, not fundamentals. Use them only as one of several inputs and don’t treat GMP as a guaranteed listing return.

Company fundamentals

(Extracted from broker/IPO information pages and the DRHP/prospectus)

Revenue (FY25): ~₹124.7 crore.
PAT (FY25): ~₹8.04 crore.
EPS (FY25): ₹5.41 per share.
NAV / Book value (per share): ₹15.87.
Reported ROE: ~34% (indicating return on equity for the reported period).

(These figures are reported in the IPO information pages and the company DRHP/prospectus.)

Valuation

Using the reported EPS ₹5.41 (FY25), we can compute the P/E at the price band:

At lower band ₹65 → P/E ≈ 65 ÷ 5.41 = 12.01.
At upper band ₹70 → P/E ≈ 70 ÷ 5.41 = 12.94.

That places the company in a low-teens P/E band versus peers in packaged/spices or small-cap food firms (investors should compare to listed peers individually — some spice companies command higher multiples while others trade lower depending on scale/brands).

Business strengths

Vertical focus on spices and blended products (ground spices, blends, whole spices) with presence across many Indian states and some exports (Middle East, Nepal, etc.).
Rapid revenue growth: Reported revenue growth from FY23 → FY25 (company reported increasing top line and improving margins).
Reasonable reported margins: improving EBITDA and PAT margins over the last few years as per IPO materials.

Key risks and caveats

Small SME listing and liquidity risk: SME listings often have lower post-listing liquidity; large investors may find it harder to exit quickly. Lot size of 2,000 also makes the per-application cheque large (₹140,000 at upper band), which can limit participation to well-funded retail or HNI investors.
GMP volatility / hype risk: Elevated GMPs can compress quickly if subscription is weak or market sentiment changes. GMP is not a substitute for valuation or due diligence.
Industry risks: Commodity price swings (spices, raw materials), agricultural seasonality, and competitive pressures from branded and regional players.
SME regulatory / disclosure differences: SME platforms have different liquidity and investor profiles compared with mainboard listings — check allotment rules and lock-ins specific to the SME offering.

Subscription / allotment & listing notes

IPO windows: Dec 22–24, 2025 (check registrar updates for allotment date).
Anchor bidding reportedly started around Dec 19 for investor anchors (anchoring can shape initial sentiment).
Proposed listing platform: NSE EMERGE (SME) — verify the final listing date with exchange notices; third-party brokers listed tentative listing dates around Dec 30, 2025 but always confirm on official exchange notices.

Shyam Dhani Industries IPO

Short-term (listing play): Elevated GMPs suggest many market participants expect sizeable listing gains. If you’re aiming purely for a short listing gain, GMPs indicate an expectation of 40%+ listing uplift — but that’s speculative and volatile. Be prepared for GMP to swing both ways pre-listing.
Medium/long term (business/valuation): At the stated EPS and price band, the P/E (≈12–13x) is modest. The company shows recent revenue growth and improving margins, which supports a constructive medium-term view — but this must be balanced against SME liquidity risk, competition, and seasonality.

Investor approach suggestions

If you want exposure but prefer lower risk: consider subscribing conservatively (one lot or skip if you lack liquidity) and avoid bidding above your target.
If you’re a listing-gain speculator: accept that GMP is an informal guide — use limit orders and plan an exit strategy.
For value investors seeking operational exposure: examine the company’s detailed RHP/DRHP, distribution reach, working-capital cycle and long-term brand or margin expansion plans before committing significant capital.